Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiography in Patients With Transcatheter Closure of Patent Foramen Ovale  by Nusser, Thorsten et al.
C
T
W
T
J
V
U
I
(
f
i
o
(
d
o
d
c
a
m
a
P
T
u
d
M
P
w
U
a
Journal of the American College of Cardiology Vol. 48, No. 2, 2006
© 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00
Pardiac Magnetic Resonance Imaging and
ransesophageal Echocardiography in Patients
ith Transcatheter Closure of Patent Foramen Ovale
horsten Nusser, MD, Martin Ho¨her, MD, FESC, Nico Merkle, MD, Olaf C. Grebe, MD,
ochen Spiess, MD, Hans A. Kestler, PHD, Volker Rasche, PHD, Matthias Kochs, MD,
inzenz Hombach, MD, Jochen Wo¨hrle, MD, FESC
lm, Germany
OBJECTIVES We studied the value of cardiac magnetic resonance imaging (CMRI) before and after closure
of patent foramen ovale (PFO) in patients with cryptogenic ischemic events.
BACKGROUND Cardiac magnetic resonance imaging is a powerful noninvasive tool for detailed assessment of
cardiac anatomy and function. The relevance of CMRI compared with transesophageal
echocardiography (TEE) in patients undergoing transcatheter PFO closure has not been
evaluated so far.
METHODS Contrast-enhanced CMRI and TEE were performed in 75 patients before and after PFO
closure. Twelve months after PFO closure, both imaging techniques were repeated in 61
patients with contrast application. To determine provokable atrial right-to-left shunting in
CMRI, we applied a contrast-enhanced perfusion imaging technique. Detection of atrial
septal aneurysm (ASA) was achieved by means of a high-resolution cine imaging technique.
RESULTS Before PFO closure, ASA was seen with CMRI in 28 of 75 cases (37.3%), compared with 47
of 75 (62.7%) cases using TEE. There were a total of 211 CMRI studies with a corresponding
TEE performed in 75 patients. No shunt was present in 107 of 211 studies with both
techniques. Contrast-enhanced right-to-left shunting was detected by CMRI in 48 of 72
(66.6%) cases with moderate or severe shunts seen with TEE, but only in 6 of 32 (18.8%)
studies with mild shunts with TEE. Anomalous venous returns were excluded in all patients.
In two patients, coronary anomalies were seen.
CONCLUSIONS The present CMRI technique is inferior to TEE in detection of contrast-enhanced
right-to-left shunting and identification of ASA. (J Am Coll Cardiol 2006;48:322–9)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.03.036© 2006 by the American College of Cardiology Foundation
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ln clinical routine, the diagnosis of patent foramen ovale
PFO) in patients with cryptogenic ischemic events and
ollow-up evaluation after closure by transcatheter device
mplantation is performed with transesophageal echocardi-
graphy (TEE). Cardiac magnetic resonance imaging
CMRI) is a powerful noninvasive diagnostic tool providing
etailed information on cardiac anatomy and function and
n hemodynamic values in patients with structural heart
isease (1). Magnetic resonance imaging after transcatheter
losure of PFO is feasible and enables evaluation of patients
fter interventional closure with a noninvasive imaging
odality (2). Recently, in a small population of 20 patients,
100% concordance with CMRI and TEE in detection of
FO and atrial septal aneurysm (ASA) was reported (3).
he value of CMRI compared with TEE in patients
ndergoing transcatheter PFO closure has not been ad-
ressed so far.
ETHODS
atients. Between May 2001 and April 2004, 75 patients
ith transcatheter closure of PFO attributable to a crypto-
From the Department of Internal Medicine II–Cardiology, University of Ulm,
lm, Germany. Drs. Nusser and Wöhrle contributed equally to this work.a
Manuscript received October 11, 2005; revised manuscript received March 1, 2006,
ccepted March 28 2006.enic ischemic event were studied by CMRI before and
fter PFO closure. If all other possible causes for an
schemic event, such as atherosclerotic plaques or stenoses of
he carotid or vertebral arteries, aortal plaques, cardiac
rrhythmias, prothrombotic coagulation disorders, and car-
iac thrombi, were excluded, the ischemic event was clas-
ified as cryptogenic. All patients underwent a workup with
2-lead electrocardiography, Holter monitoring, Doppler
onography, transthoracic echocardiography, TEE, and co-
gulation blood tests. All patients were in sinus rhythm, and
here was no indication for oral anticoagulation because of
ther disorders. The study was approved by the local ethics
ommittee. All patients gave their written informed consent
or the PFO closure as well as TEE and CMRI studies.
EE. The TEE was performed with a multiplane phased
rray 4- to 7-MHz TEE probe on an ATL HDI 5000 CV
Philips Medical Systems, Best, the Netherlands). For
ontrast enhancement we administered repeatedly 10 ml of
gitated hydroxyethyl starch solution into an antecubital
ein with the patient performing a proper Valsalva maneu-
er (4). Provocable right-to-left shunt was graded according
o the amount of bubbles crossing the interatrial septum: no
hunt  0, mild shunt  1 to 9 bubbles, moderate shunt 
0 to 20 bubbles, and severe shunt20 bubbles or opacified
eft atrium because of bright contrast. An ASA was defined
s an excursion of the atrial septum 10 mm (5).
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July 18, 2006:322–9 CMRI in Patients With Closure of PFOagnetic resonance imaging. The CMRI was performed
n a 1.5-T Intera CV whole-body MR Scanner (Philips
edical Systems). The scanner was equipped with a high-
erformance gradient system, providing a maximal gradient
trength of 30 mT/m and a maximal slew rate of 150
T/ms. All data were acquired using a dedicated five-
lement cardiac phased-array coil.
To determine left and right ventricular function, a retro-
pective electrocardiography-gated segmented k-space bal-
nced turbo-field echo sequence (steady-state free preces-
ion [SSFP]) without view sharing was used in short-axis
nd long-axis views along the true heart axis. Depending on
he required field of view, the spatial resolution was between
.7  1.8 mm and 2.3  1.8 mm in-plane, with a slice
hickness of 10 mm. Echo time TE and repetition time TR
ere chosen as TE  1.7 ms and TR  3.4 ms. The RR
nterval was separated into 32 equidistant phases, which
esulted into an effective temporal resolution or TRR/32 ms
er image, with TRR being the average RR cycle length in
icroseconds.
The atrial septum was scanned using similar short-axis
ine images with a higher spatial resolution (1.5  1.7 mm
n-plane), 8-mm slice thickness, and 39 phases per RR
ycle, resulting in an effective temporal resolution of TRR/39
s. The membranous part and total atrial septum were
easured in short-axis and long-axis views. The ASA in
MRI was defined as the maximal extent of oscillation of
he atrial septum 10 mm based on the definition of ASA
n TEE (5).
To determine provocable atrial right-to-left shunting in
MRI, we performed two contrast-enhanced sequences in
short-axis view and a long-axis four-chamber view, chosen
rom the localization of the fossa ovalis in the cine studies.
n all patients we used continuous perfusion imaging apply-
ng a SSFP sequence. To improve the contrast agent
ensitivity of the sequence, a selective saturation recovery
repulse (delay 115 ms to k-space center coverage) was
pplied before the acquisition of each image. Image acqui-
ition parameters were: repetition time TR  2.8 ms, echo
ime TE  1.4 ms, slice thickness 10 mm, matrix 176 
56, in-plane-resolution 2.1 2.6 mm, and a reconstructed
oxel size of 1.48  1.48  10 mm. Further increase of the
emporal resolution was achieved by parallel imaging tech-
iques with a reduction factor of 2, by restriction of the data
cquisition to the central 80% of k-space, and by using an
5% rectangular field of view. The acquisition time of a
Abbreviations and Acronyms
ASA  atrial septal aneurysm
CMRI  cardiac magnetic resonance imaging
Gd-DTPA  gadolinium-diethylenetriaminepentaacetate
PFO  patent foramen ovale
SSFP  steady-state free precession
TEE  transesophageal echocardiographyingle image was 168 ms, which, in combination with the aaturation prepulse, yielded an overall acquisition time of
00 ms per image. During visualization of the bolus,
maging was performed continuously at a frame rate of five
mages per second. A bolus of 0.1 mmol/kg body weight
adolinium-diethylenetriaminepentaacetate (Gd-DTPA)
Magnevist, Schering AG, Berlin, Germany) was injected
nto an antecubital vein by a power injector (Medrad
pectris, Volkach, Germany) at a rate of 4 ml/s flushed with
0 ml saline while patients performed a Valsalva maneuver
dentical to the TEE procedure. Two independent reviewers
erformed all analyses regarding assessment of contrast-
nhanced right-to-left shunting. If both reviewers dis-
greed, a third reviewer was consulted and discussion was
erformed until consensus was achieved. All reviewers were
linded to the TEE data. Patients were classified to have a
ontrast-enhanced right-to-left shunt if there was a clear
ontrast passage seen in the perfusion scans and/or there
as a clear peak in the left atrium at the same time as the
eak in the right atrium was visible in the time-intensity
urves (Fig. 1). The regions of interest were placed in the
eft atrium close to the atrial septum and in the right atrium
nd were manually fitted to every image.
Flow measurements in the main pulmonary artery and
scending aorta were performed by means of a conventional
hase contrast technique retrospective gating with free
reathing (field of view 300 mm, slice thickness 6 mm). Left
nd right ventricular function and volumetry as well as
uantification of flow measurements were carried out on an
asyVision workstation (Philips Medical Systems). We
arefully performed shunt quantification according to the
ethod described in detail by Araoz et al. (6) using left and
ight ventricular volumetry as well as flow measurements.
utoff for detectable shunts by CMRI was set to 5% of
ardiac output. For detection of pulmonary veins, we per-
ormed an electrocardiography-gated transversal stack of
2-weighted turbo spin echo sequences with a black-blood
repulse and a slice thickness of 5 mm (6).
FO closure. The Cardia Star (Cardia, Inc., Burnsville,
innesota) closure device was implanted in the catheter
aboratory under fluoroscopic and TEE guidance as de-
cribed by Braun (7). Procedures were performed in local
nesthesia and facultative sedation with midazolam and
ropofol. After implantation of the device, contrast-
nhanced TEE was performed to detect residual right-
o-left shunting. All patients received a combined anti-
latelet therapy with 100 mg acetylsalicylic acid and 75
g clopidogrel per day for 6 months. For prophylaxis of
ndocarditis, cephazolin 2 g before the intervention and
h after closure were administered.
ollow-up. Patients were scheduled for clinical and TEE
ontrol 3 months after PFO closure. The CMRI and TEE
ere performed on the same day 12 months after device
mplantation.
tatistics. Data were analyzed using a chi-square test. To
ompare differences between means, the Student t tests were
pplied. The Bonferroni correction was used to account for
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CMRI in Patients With Closure of PFO July 18, 2006:322–9ype I error caused by multiple testing. Statistical analysis
as done with Statistica version 6.0 (StatSoft Inc., Tulsa,
klahoma). Values of p 0.05 were considered statistically
ignificant.
ESULTS
atients. All patients had experienced cryptogenic ischemic
vents. Baseline characteristics are shown in Table 1. The
MRI was performed at a median of 1 day before (range 0
o 89 days) and 1 day after (range 0 to 13 days) PFO closure
igure 1. The time intensity curves of the same patient as in Figure 2
erforming a Valsalva maneuver. The blue line represents the signal inten
trium. The blue line shows its maximal peak earlier than the red line
ntravenously administered contrast agent. The black arrow indicates the co
efore the maximal peak in the left atrium.
able 1. Patient Characteristics
atients, n 75
ean age (yrs) 48.5  12.7
ale, n 45 (60.0%)
ndex event, n
Stroke 51 (68.0%)
TIA/PRIND 21 (28.0%)
Peripheral arterial embolism 1 (1.3%)
Embolic myocardial infarction 2 (2.7%)
ardiovascular risk factors, n
Diabetes 4 (5.3%)
Hypertension 31 (41.3%)
History of smoking 32 (42.7%)
Hyperlipidemia 29 (38.7%)
Body mass index 26.1  3.8
oronary artery disease, n 6 (8.0%)
ays from index event to intervention, median (range) 85 (4–193)P
RIND  prolonged reversible ischemic neurological deficit; TIA  transient
schemic attack.nd was repeated in 64 (85.3%) patients after a median of
60 days (range 237 to 441 days). All patients received TEE
efore and after PFO closure. The TEE was repeated after
months in 73 (97.3%) patients and after 12 months in 63
84%) patients. Three patients received only CMRI at
2-month follow-up refusing TEE. Two patients received
nly TEE at 12-month follow-up, refusing CMRI exami-
ation. A total of 66 f 75 patients received at least one
maging technique at 12-month follow-up. One patient
nderwent open-heart surgery. The remaining 8 patients
eceived scheduled TEE control 3 months after device
mplantation but refused imaging evaluation at 12-month
ollow-up because of a clinically asymptomatic course.
EE versus CMRI. Separation of septum primum and
eptum secundum was detected in all patients with TEE
ompared with 56 of 75 (74.7%) patients with CMRI (p 
.0001). An ASA was seen with CMRI in 28 of 75 (37.3%)
atients compared with 62.7% (47 of 75) with TEE (p 
.0019). Figure 2 shows a series of SSFP sequences in a
atient with PFO and ASA. Cine sequences showed a clear
ontrast-enhanced right-to-left shunt and ASA before clo-
ure. The corresponding time-intensity curves are shown in
igure 1 (for perfusion sequences and four-chamber view
ine sequences before PFO closure and at 12 months, see
nline Video 1 to 4). There was no multiple perforated
trial septum or additional atrial septal defect. Detection of
g a contrast-enhanced cardiac magnetic resonance imaging study while
the right atrium, and the red line denotes the signal increase in the left
se of the earlier contrast enhancement of right versus left atrium after
t passage over the patent foramen ovale showing an additional smaller peakdurin
sity in
becauFO by contrast-enhanced right-to-left shunting during
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July 18, 2006:322–9 CMRI in Patients With Closure of PFOalsalva maneuver significantly differed between both im-
ging methods. Based on our inclusion criteria, all 75
atients had contrast-enhanced right-to-left shunting via
FO in TEE. In contrast, before intervention CMRI
howed evidence of a provocable right-to-left shunt in only
8 of 75 (64.0%) patients (p  0.0001).
To exclude a potential clinical learning curve, we divided
ur study population into three equal subgroups (25 patients
ach). The first subgroup represents the patients recruited
uring the first 12.5 months of the inclusion period, the
econd subgroup consists of the patients included during the
ollowing 12.5 months, and the third subgroup is the
atients recruited within the last 10 months. The CMRI
howed contrast-enhanced right-to-left shunting in the first
igure 2. A series of steady-state free-precession sequences in a patient w
nd (B) a short-axis view before interventional closure. The two arrows ind
ranscatheter closure in (C) a four-chamber view and (D) a short-axis view
to 4).ubgroup in 17 of 25 (68%) patients, in the second subgroup on 13 of 25 (52%) patients, and in the third subgroup in 18
f 25 (72%) of patients.
After PFO closure, residual contrast-enhanced right-
o-left shunting was seen in 25.3% of patients (19 of 75)
ith TEE and in 6.7% of patients (5 of 75) with CMRI
p  0.002). Both imaging techniques with contrast
pplication were performed in 61 patients at follow-up.
n these patients, a residual contrast-enhanced shunt was
een with TEE in 16.4% (10 of 61) and with CMRI in
.6% (1 of 61; p  0.0044). The time course of residual
ontrast-enhanced right-to-left shunting seen with TEE is
etailed in Figure 3.
There were a total of 211 CMRI investigations with their
orresponding TEE before intervention, after intervention,
tent foramen ovale and atrial septal aneurysm. (A) A four-chamber view
the separated atrial septum. The same patient at 12-month follow-up after
arrows point at the closure device (for cine sequences, see Online Videosith pa
icate
. Ther at 12-month follow-up with contrast application to assess
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CMRI in Patients With Closure of PFO July 18, 2006:322–9ight-to-left shunting during Valsalva maneuver. In these
11 studies, TEE showed moderate or severe shunts in 72
tudies and mild shunts in 32 studies. The CMRI detected
8 of 72 (66.6%) of these moderate or severe shunts seen
ith TEE, but only 6 of 32 (18.8%) of the mild shunts. No
ontrast-enhanced shunt was present in 107 cases with both
maging modalities.
MRI. A visible left-to-right jet with CMRI cine se-
uences without contrast agent was only present in 2 of 75
2.7%) patients before PFO closure. On flow measurements,
ortic cardiac output was 5.7  1.1 l/min, pulmonary
ardiac output was 5.9  1.1 l/min, aortic stroke volume
as 86 17 ml, and pulmonary stroke volume was 88 17
l. By careful shunt quantification, we were able to
alculate systemic shunts before intervention in 18 of 75
24.0%) patients with a mean shunt fraction of 7.6 
.3% (range 5.0% to 13.0%) of cardiac output. We
ttributed this shunt fraction to the PFO because anom-
lous pulmonary venous return could be excluded in all
atients by CMRI and TEE, and no evidence for other
ystemic intracardiac shunts was seen, neither with
MRI nor with TEE. After PFO closure, only in one
atient did a 10.0% continuous shunt remain, disappear-
ng until 12-month follow-up.
In two patients we assumed an anomalous origin of a
oronary artery in the transversal stack of black-blood
mages. For a better assessment, we performed additional
cans using targeted SSFP sequences for visualization of
oronary arteries in CMRI and confirmed the anomalous
rigin by cardiac catheterization. One patient had a separate
rigin of the dominant right coronary artery next to the left
inus of Valsalva. In the other patient, the left main
oronary artery arose from the right sinus of Valsalva with
igure 3. This plot shows the grade of provocable right-to-left shunting
chocardiography (TEE) before transcatheter closure, after device implantn interarterial course between the aorta and the pulmonary
f
vain vessel. Neither patient suffered from ischemic heart
isease.
In CMRI, total atrial septum measured 46.6 8.8 mm in
our-chamber view and 41.0  8.6 mm in short-axis view.
he membranous portion measured 21.8  6.5 mm in
our-chamber view and 22.6  6.5 mm in short-axis view.
here was no statistical difference in hemodynamic values,
eft and right ventricular parameters between CMRI before
FO closure, and at 12-month follow-up (Table 2; 11
omparisons included in the Bonferroni adjustment). Sub-
roup analysis of patients with systemic shunts before
patent foramen ovale (PFO) in 75 patients assessed by transesophageal
, and at follow-up.
able 2. Hemodynamic Values, Right and Left Ventricular
arameters Assessed by Cardiac Magnetic Resonance Imaging
n  64 Prior PFO Closure Follow-Up
eft atrial diameter (mm) 36.3  5.8 35.8  4.7
eft ventricular parameters
LVEDV (ml) 136.3  33.7 134.3  33.5
LVESV (ml) 45.7  18.8 43.1  17.0
LVEF (%) 67.3  7.2 68.6  6.7
LVEDVI (ml/m2) 71.3  14.5 70.0  15.0
LVESVI (ml/m2) 23.8  8.7 22.4  8.1
ight ventricular parameters
RVEDV (ml) 146.6  35.8 145.6  35.8
RVESV (ml) 55.0  19.4 53.5  18.1
RVEF (%) 63.2  6.0 64.0  5.1
emodynamic parameters
CI (l/min/m2) 3.1  0.5 3.1  0.5
CO (l/min) 5.9  1.1 5.9  1.2
HR (beats/min) 65.6  9.1 65.4  10.2
easurements are mean  standard deviation.
CI  cardiac index; CO  cardiac output; HR  heart rate; LVEDV  left
entricular end-diastolic volume; LVEDVI  left ventricular end-diastolic volume
ndex; LVEF  left ventricular ejection fraction; LVESV  left ventricular end-
ystolic volume; LVESVI left ventricular end-systolic volume index; PFO patent
oramen ovale; RVEDV  right ventricular end-diastolic volume; RVEF  right
entricular ejection fraction; RVESV  right ventricular end-systolic volume.
i
1
w
c
o
t
A
8
3
m
l
s
c
D
T
t
e
e
l
f
P
o
v
l
C
P
i
c
r
i
i
o
w
f
s
T
t
F
o ton-w
h ired b
327JACC Vol. 48, No. 2, 2006 Nusser et al.
July 18, 2006:322–9 CMRI in Patients With Closure of PFOntervention also showed no change in these parameters at
2-month follow-up.
The CMRI showed further information in two patients
ith severe complications during follow-up. Both compli-
ations were also visible in TEE. One patient underwent
pen-heart surgery for a dislocated spoke of the closure device
hat nearly perforated the aortic root (see Online Video 5).
nother asymptomatic patient showed a new 60  45 
0-mm structure cranial and lateral to the right atrium at
-month control (Fig. 4). There was no contrast enhance-
ent with any evidence of central perfusion, suggesting a
arge paracardial hematoma. At 25-month follow-up, the
tructure had totally dissolved. Both patients recovered
ompletely without long-term sequelae.
ISCUSSION
his is the first large study to assess the value of CMRI in
he detection of PFO and ASA in patients with transcath-
ter closure of PFO. In comparison with TEE, contrast-
igure 4. A new structure next to the right atrium was seen on cardiac magn
vale. (A) Four-chamber view steady-state free precession sequence, (B) pro
ad completely disappeared, which is shown in (C) and (D), images acqunhanced right-to-left shunting was detected significantly pess frequent with CMRI. An ASA was significantly more
requently detected with TEE compared with CMRI before
FO closure. The CMRI revealed additional information
n the size of left atrium, atrial septum, left and right
entricular parameters, and hemodynamic values. Anoma-
ous venous return could be excluded in all patients with
MRI.
FO. We included 75 patients with a total of 211 CMRI
nvestigations. For each CMRI study, we performed its
orresponding TEE study to detect contrast-enhanced
ight-to-left shunting. The CMRI is clearly inferior to TEE
n the detection of contrast-enhanced right-to-left shunt-
ng. A mild shunt seen in TEE was detected with CMRI
nly in 19% of cases. Moderate or severe shunts with TEE
ere seen in 67% of cases with CMRI. Especially at
ollow-up after PFO closure, TEE revealed no moderate or
evere shunts, limiting the diagnostic impact of CMRI.
hese results are probably based on a lower spatial and
emporal resolution of CMRI perfusion sequences com-
esonance imaging 3 months after interventional closure of a patent foramen
eighted coronal turbo spin echo. After 25 months the supposed hematoma
y a T2-weighted black-blood technique.etic rared with TEE. The volumetric and hemodynamic data,
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CMRI in Patients With Closure of PFO July 18, 2006:322–9hich were in the normal range for patients without
tructural heart disease (8), confirms our inclusion criteria of
atients with cryptogenic ischemic events.
There is only one other trial dealing with the detection of
FO with CMRI compared with TEE (3), showing a 100%
oncordance in the detection of PFO between both imaging
echniques. This apparently perfect equivalence was based
n only 20 corresponding CMRI and TEE studies, whereas
ur trial is based on 211 corresponding CMRI and TEE
nalyses performed in 75 patients. To detect a contrast-
nhanced right-to-left shunt in patients with PFO, it is
rucial to perform a proper Valsalva maneuver (4). We paid
reat attention to performing a proper Valsalva maneuver
ith the patient being in the MRI scanner. To do so, it is
ndispensable to precisely find the point in time at which the
ontrast agent reaches the right atrium to release the
alsalva maneuver. The pressure in the right atrium exceeds
he pressure in the left atrium just after release of the
alsalva maneuver. There will be no detectable right-to-left
hunt if the Valsalva maneuver is released too early, because
he right atrium is not yet filled by the contrast agent. If the
alsalva maneuver is released too late, then the contrast
gent filling the left atrium is already inflowing from the
ulmonary veins (normal pulmonary circulation time, 4 to
s). Hence, there must be an acceptable temporal resolution
o perform a proper Valsalva maneuver. We were able to
ttain a temporal resolution of 200 ms resulting in a frame
ate of 5 images/s compared with Mohrs et al. (3) with 832
s acquiring only one image every heartbeat. We did not
ompare the signal-time curves in the left atrium to that in
he pulmonary vein as done by Mohrs et al. (3) because
here are four pulmonary veins with differences in blood
ow causing differences in contrast enhancement depending
n which pulmonary vein is visualized. Mohrs et al. (3) did
ot optimize the axis of the perfusion sequences with
espect to the localization of the pulmonary veins as the
maging technique was optimized for PFO. In case that the
eft atrium has already been contrasted because of a faster
ccurrence via the nonvisualized pulmonary veins, their
esults could be biased when finding the perfect correlation
etween TEE and CMRI. This could be an explanation of
heir results in patients with grade 1 or 2 shunts with TEE.
hree of these five patients showed a higher PFO grade
ith CMRI compared with TEE. Indeed, there was one
atient with a grade 1 shunt with TEE (3 to 9 bubbles)
howing a grade 3 shunt with CMRI defined by a bright
ontrast enhancement in the left atrium before the
ontrast agent reached the pulmonary veins. The influ-
nce of their results by detection of contrast in the left
trium because of contrast filling via nonvisualized pul-
onary veins is supported by their own data (3). In two
atients of that control group with no PFO with TEE,
he time to peak in the pulmonary vein was longer than
he time to peak in the left atrium. Because PFO was
xcluded by TEE, the faster contrast filling of the left
trium before contrast filling of the pulmonary vein can only be explained by a more rapid filling of the left atrium
ia nonvisualized pulmonary veins.
SA. The TEE allows continuous visual interpretation of
he atrial septum with detection of ASA in 63% of our
atients. In contrast, CMRI revealed ASA in 37% of
atients. We used the best technique in both imaging
tudies to get the clinically important information on the
resence or absence of an ASA. These techniques include
alsalva maneuver in TEE but not in CMRI studies. The
erformance of a Valsalva maneuver is basically possible
ith CMRI. However, the maximal oscillation of the atrial
eptum occurs after release of the Valsalva maneuver. To
apture this extremely short moment, a high temporal
esolution is necessary, and to visualize the atrial septum, a
igh spatial resolution is necessary. Real-time CMRI could
rovide the temporal but not the spatial resolution to
isualize the oscillation of the atrial septum. High-
esolution cine sequences provide the spatial resolution but
re hampered by the acquisition over several heartbeat cycles
nd therefore do not allow one to detail the very short
eriod of time after release of the Valsalva maneuver.
urthermore, in TEE studies the atrial septum was scanned
n multiple planes, allowing selection of the maximal extent
f oscillation, whereas in CMRI at first the atrial septum
as scanned, and after image acquisition the maximal extent
f oscillation was measured. There may be an advantage for
MRI in patients not tolerating the TEE probe with the
ubsequent need for deep sedation, which prevents the
erformance of a proper Valsalva maneuver. Nevertheless,
his is an important limitation of CMRI because PFO with
SA is at present considered to be associated with a high
isk for recurrent ischemic events (9,10).
ystemic shunts. The CMRI is the best technique for
uantification of continuous systemic shunts (6,11). The
EE studies with color Doppler have shown continuous
lood flow via the PFO shunting from the right to the left
trium and vice versa. We investigated whether in patients
ith PFO systemic shunts were measurable using CMRI.
n patients with PFO we detected a continuous systemic
hunt in 24% of patients, with a mean shunt fraction of
.6%. Follow-up CMRI showed complete disappearance of
hese continuous shunts after successful transcatheter clo-
ure of PFO. These continuous systemic shunts are unlikely
o have any relevant hemodynamic impact because our
olumetric and hemodynamic data were within the normal
ange and did not change during follow-up.
ardiac anomalies. According to present guidelines,
MRI is indicated to detect anomalous venous returns (12),
hich are often associated with atrial septal defects. The
requency of an association with PFO is generally not
valuated. The detection of an anomalous venous return in
ombination with a PFO after a cryptogenic ischemic event
ay favor surgical treatment. The CMRI is superior to
-ray angiography or transthoracic echocardiography in
etection of anomalous venous returns (13). The assessment
f pulmonary veins with modern multiplane TEE is more
r
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July 18, 2006:322–9 CMRI in Patients With Closure of PFOeliable (14). We were able to detect four pulmonary veins
eturning to the left atrium in all 75 patients with both
maging modalities and equated this information with the
xclusion of an anomalous venous return. Moreover, the
bsence of a measurable shunt after PFO closure excludes a
ignificant accessory pulmonary vein.
In addition, due to all imaging acquisitions we assumed
n anomalous origin of a coronary artery in 2 of our 75
atients. To confirm this diagnosis, we performed addi-
ional scans in these two patients using targeted SSFP
equences for visualization of coronary arteries in CMRI
nd confirmed these anomalies by cardiac catheterization.
sually PFO closure is performed without coronary angiog-
aphy. The detection of an anomalous origin of coronary
rteries with CMRI may be important because compression
f the circumflex artery with an anomalous origin from the
ight coronary sinus after device closure of PFO has been
escribed (15).
With CMRI we were able to gain additional information in
oth patients with severe complications. The two umbrellas of
he occluder are expanded by nitinol wires. Although peripro-
edural TEE and fluoroscopy showed a correct position of
oth occluders during the implantation procedure, the stress of
he nitinol wires on the atrial wall during cardiac contraction
ay have induced perforation of the atrium.
tudy limitations. The study included patients with PFO
nd contrast-enhanced right-to-left shunting with TEE and
ndication for transcatheter PFO closure because of crypto-
enic ischemic events. These inclusion criteria limit the poten-
ial value of CMRI because only patients with a positive TEE
ere included. We did not perform contrast-enhanced mag-
etic resonance angiography to exclude anomalous pulmonary
enous returns, which would be superior to black-blood MRI,
specially in detection of an accessory pulmonary vein. Never-
heless, the lack of left-to-right shunting after PFO closure can
e used to exclude any significant shunt attributable to an
ccessory pulmonary vein.
onclusions. The present CMRI technique is inferior to
EE in the detection of contrast-enhanced right-to-left
hunting during Valsalva maneuver and identification of
SAs.
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